Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis M Galli, S Benenati, D Capodanno, F Franchi, F Rollini, D D'Amario, ... The Lancet 397 (10283), 1470-1483, 2021 | 208 | 2021 |
Antiplatelet therapy after percutaneous coronary intervention DJ Angiolillo, M Galli, JP Collet, A Kastrati, ML O'Donoghue EuroIntervention 17 (17), e1371, 2022 | 175 | 2022 |
Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials M Galli, S Benenati, F Franchi, F Rollini, D Capodanno, G Biondi-Zoccai, ... European heart journal 43 (10), 959-967, 2022 | 145 | 2022 |
Microvascular dysfunction in heart failure with preserved ejection fraction D D’Amario, S Migliaro, JA Borovac, A Restivo, R Vergallo, M Galli, ... Frontiers in physiology 10, 1347, 2019 | 121 | 2019 |
Coronary atherosclerotic phenotype and plaque healing in patients with recurrent acute coronary syndromes compared with patients with long-term clinical stability: an in vivo … R Vergallo, I Porto, D D’Amario, G Annibali, M Galli, S Benenati, ... JAMA cardiology 4 (4), 321-329, 2019 | 119 | 2019 |
Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs G Patti, I Cavallari, F Andreotti, P Calabro, P Cirillo, G Denas, M Galli, ... Nature Reviews Cardiology 16 (2), 113-130, 2019 | 103 | 2019 |
Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis … L Ortega-Paz, M Galli, D Capodanno, F Franchi, F Rollini, B Bikdeli, ... European Heart Journal-Cardiovascular Pharmacotherapy 8 (7), 677-686, 2022 | 73 | 2022 |
Neoatherosclerosis after drug-eluting stent implantation: a novel clinical and therapeutic challenge JA Borovac, D D’Amario, R Vergallo, I Porto, A Bisignani, M Galli, ... European Heart Journal–Cardiovascular Pharmacotherapy 5 (2), 105-116, 2019 | 65 | 2019 |
Very short vs. long dual antiplatelet therapy after second generation drug-eluting stents in 35 785 patients undergoing percutaneous coronary interventions: a meta-analysis of … S Benenati, M Galli, V De Marzo, F Pescetelli, M Toma, F Andreotti, ... European Heart Journal-Cardiovascular Pharmacotherapy 7 (2), 86-93, 2021 | 59 | 2021 |
Intracranial haemorrhages vs. stent thromboses with direct oral anticoagulant plus single antiplatelet agent or triple antithrombotic therapy: a meta-analysis of randomized … M Galli, F Andreotti, I Porto, F Crea EP Europace 22 (4), 538-546, 2020 | 53 | 2020 |
Management of coronary artery disease in older adults: recent advances and gaps in evidence S Cacciatore, L Spadafora, M Bernardi, M Galli, M Betti, F Perone, ... Journal of clinical medicine 12 (16), 5233, 2023 | 44 | 2023 |
Role of platelet function and genetic testing in patients undergoing percutaneous coronary intervention M Galli, F Franchi, F Rollini, DJ Angiolillo Trends in cardiovascular medicine 33 (3), 133-138, 2023 | 42 | 2023 |
Genetic testing in patients undergoing percutaneous coronary intervention: rationale, evidence and practical recommendations M Galli, F Franchi, F Rollini, LH Cavallari, D Capodanno, F Crea, ... Expert review of clinical pharmacology 14 (8), 963-978, 2021 | 42 | 2021 |
Where does inflammation fit? LM Biasucci, G La Rosa, D Pedicino, A D’Aiello, M Galli, G Liuzzo Current cardiology reports 19, 1-10, 2017 | 42 | 2017 |
Coronary microvascular obstruction and dysfunction in patients with acute myocardial infarction M Galli, G Niccoli, G De Maria, S Brugaletta, RA Montone, R Vergallo, ... Nature Reviews Cardiology 21 (5), 283-298, 2024 | 41 | 2024 |
Colchicine in ischemic heart disease: the good, the bad and the ugly D D’Amario, D Cappetta, L Cappannoli, G Princi, S Migliaro, G Diana, ... Clinical research in cardiology 110, 1531-1542, 2021 | 41 | 2021 |
Factor XI inhibitors in early clinical trials: a meta-analysis M Galli, R Laborante, L Ortega-Paz, F Franchi, F Rollini, D D'Amario, ... Thrombosis and Haemostasis 123 (06), 576-584, 2023 | 39 | 2023 |
Precision medicine in interventional cardiology: implications for antiplatelet therapy in patients undergoing percutaneous coronary intervention M Galli, L Ortega-Paz, F Franchi, F Rollini, DJ Angiolillo Pharmacogenomics 23 (13), 723-737, 2022 | 36 | 2022 |
De-escalation of antiplatelet therapy in acute coronary syndromes: why, how and when? M Galli, DJ Angiolillo Frontiers in cardiovascular medicine 9, 975969, 2022 | 35 | 2022 |
Antithrombotic therapy in the early phase of non-ST-elevation acute coronary syndromes: a systematic review and meta-analysis M Galli, F Andreotti, D D’Amario, R Vergallo, GM Vescovo, L Giraldi, ... European Heart Journal-Cardiovascular Pharmacotherapy 6 (1), 43-56, 2020 | 34 | 2020 |